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CHANGE IN MRI SYNOVITIS CORRELATES WITH CHANGE IN PAIN
FOLLOWING INTRA-ARTICULAR STEROID INJECTION
T.W. O'Neill y, L.M. Forsythe y, M.J. Parkes y, E. Marjanovic y, A. Gait y, C.E.
Hutchinson z, T.F. Cootes y, D.T. Felson y. y The Univ. of Manchester,
Manchester, United Kingdom; zUniv. of Warwick, Coventry, United
Kingdom
Purpose: Synovitis is a well recognised ﬁnding in knee osteoarthritis. It
can be identiﬁed on Magnetic Resonance Imaging (MRI) as synovial
thickening, although injection of contrast material is required to
distinguish synovial tissue from synovial ﬂuid. The aim of this analysis
was to determinewhether change in synovial tissue volume as assessed
using gadolinium (Gd) enhancedMRI imaging correlates with change in
knee pain following intra-articular steroid therapy.
Methods: Men and women aged 40 years and older who met ACR
criteria for the disease, were recruited for participation in an ongoing
open label clinical trial of intra-articular steroid therapy. Subjects who
took part in the study had signiﬁcant knee pain and grade 2 or higher
knee OA. At baseline visit they completed a questionnaire about their
symptoms including KOOS pain scale (100 ¼ no pain to 0 ¼ extreme
pain) and also a VAS score (0 ¼ no pain] to 10 ¼ extreme pain) for pain
on a nominated activity (VASnA). They subsequently had a Gd enhanced
MRI immediately prior to having an intra-articular steroid injection
with repeat questionnaire and Gd-enhanced MRI scan at follow up visit
to assess synovial response usually within 2 weeks after the injection.
To assess synovial tissue volume, sagittal (post CE T1W Fat Suppressed
images: TR 500ms, TE 17ms; FoV 15.9 x 15.9cm; slice thickness 3mm)
scans were obtained. Manual segmentation of the synovial tissue layer
was performed on the post contrast knee image by a single observer.
Using computer image analysis we excluded cartilage within the
segmented space, by thresholding in the associated sagittal (3DWATSc:
TR 20ms, TE 7.7ms, FoV 15cm, 288x288) scan. The rest of the segmented
space was assumed to be a mixture of ﬂuid and synovial tissue. We
calculated the proportion of synovial tissue in every voxel using P ¼ (I -
mf) / (ms - mf) truncated to [0,1], where I is the voxel intensity and mf,
ms are the means of the intensity distributions of ﬂuid and synovial
tissue volume respectively. We looked at mean synovial volume before
and after the steroid injection and looked at the Spearman Rank
correlation coefﬁcient between change in synovial volume and change
in the level of KOOS-pain and also VASnA.
Results: We analysed data from 41 patients. Their mean age was 62.4
years (SD 10.5 years), and 21 were female (51.2%). The median time
between baseline and follow up scan was 9 days (IQR 7 to 14 days). The
median synovial tissue volume at baseline was 7,556mm3 (IQR4,670mm3 to 11,269 mm3), and at follow up was 7,078mm3 (IQR
3,642mm3 to 8,541mm3); median difference -1,007mm3 (95% CI
-1,909mm3 to -320mm3). Both KOOS pain (24.7pts; 95% CI 18.4 pts to
31.0 pts) and VASnA (-3.2cm; 95% CI -4.1cm to -2.2cm) improved
signiﬁcantly between baseline and follow up. The change in synovial
tissue volume correlated with change in VASnA (rs ¼ 0.39; p ¼ 0.01)
though not with KOOS-pain (rs ¼ -0.11 ; p ¼ 0.50). Change in VASnA did
not appear to correlate with synovial tissue volume at baseline (rs ¼
-0.03; p¼0.85); nor did change in KOOS pain (rs ¼ 0.17; p¼0.30).
Conclusions: Synovial tissue volume in knee osteoarthritis, assessed
with Gd-enhanced MRI correlates with change in pain assessed as pain
on a nominated activity, though not KOOS, in response to intra-articular
steroid injection.586
A SYSTEMATIC REVIEW OF WHERE AND HOW TO INJECT IN THE
KNEE?
N. Maricar, M.J. Parkes, M.J. Callaghan, D.T. Felson, T.W. O'Neill. The
Univ. of Manchester, Manchester, United Kingdom
Purpose: The knee can be injected at different anatomic sites with or
without image-guidance. We undertook a systematic review to deter-
mine i) the accuracy of intra-articular knee injection (IAKI) andwhether
this varied by site, use of image-guidance and clinician experience, and
ii) whether accuracy of IAKI was linked with improved therapeutic
response.
Methods:Medline, Embase, AMED, CINAHL, Web of Knowledge and the
Cochrane Central Registers for Controlled Trials up to July 2012 were
searched including additional hand searches of relevant articles. Studies
included were those that evaluated accuracy of steroid injection at one
or more IAKI sites performed either blinded or using image-guidance.
We pooled data across studies to determine accuracy and also differ-
ences in accuracy by injection site when injections were delivered blind
or guided by imaging. Using data from the small number of studies
which permitted within-study comparisons, we performed meta-
analyses (ﬁxed effect model with forest plot) to determine differences
in accuracy of blind and guided injections.
Results: Data from 26 publications were included in the review. Only 5
studies were available for within-study comparison for 4 out of the 8
injection sites. The within-study analyses found guided IAKIs at
superomedial patellar (SMP), medial midpatellar (MMP), superolateral
patellar (SLP) and lateral suprapatellar bursa (LSB) had greater accuracy
using image-guidance than given blind [pooled risk difference 0.09-
0.19]. Using between-study analyses, for blinded IAKIs, the SLP site was
the most accurate [87%] though SMP and lateral sites such as lateral
mid-patellar (LMP) and LSB were also accurate [pooled accuracies 82-
84%]. Overall about one in ﬁve blinded IAKIs were inaccurate. Using data
pooled across studies the MMP [Absolute Risk Difference (ARD) 0.22,
95% Conﬁdence Interval (CI) 0.10-0.33] and the anterolateral joint line
injection approaches [ARD 0.28, 95% CI 0.20-0.35] were least accurate
when performed blinded compared to when performed guided. Overall
there was no signiﬁcant difference in accuracy between the lateral
injection sites and the medial sites [Blinded: ARD 0.04, 95% CI 0.00 to
0.08; Guided: ARD 0.01, 95%CI -0.01 to 0.03]. Adverse events associated
with IAKI at different sites were uncommon, though compared to the
lateral approach, the medial approach was associated with a higher
frequency of adverse events. There was some evidence that experience
of the injector was linked with improved accuracy for blinded though
not image-guided injections. There was no association between accu-
racy of IAKIs and treatment outcome though therewas a paucity of data.
Conclusions: IAKIs are safe and can be accurate when performed blind
depending on injection site. The use of image guidance improves
accuracy of IAKI at all sites. Further studies are required to address the
question whether accurate localisation is linked with a better outcome.587
COMPARATIVE EFFECTIVENESS OF TWO HYALURONIC ACID
FORMULATIONS ON PERCEIVED FUNCTIONAL PERFORMANCE
J. Zeni, Jr. y, L. Snyder-Mackler y, M. Axe y,z. yUniv. of Delaware, Newark,
DE, USA; z First State Orthopaedics, Newark, DE, USA
Purpose: Intra-articular hyaluronic acid (HA) injections are a non-
surgical treatment for knee osteoarthritis (OA) that have the potential to
reduce pain and improve functional ability. Despite potential beneﬁts,
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S301not all patients that receive HA injections have an optimal response.
Several different HA formulations are available and a comparative
analysis of outcomes is lacking in the literature. Therefore, the purpose
of this study was to quantify the functional beneﬁt of two different HA
formulations for individuals with knee OA.
Methods: The Knee Outcome Survey (KOS) and Global Rating Score
(GRS) from patients who received HA injections for knee OA were
analyzed. Patients with bilateral injections completed a questionnaire
for each limb. Baseline KOS and GRS scores prior to injection and scores
4-6 weeks after the last injectionwere compared between subjects who
received 5 Sodium Hyaluronate (Supartz) injections (n ¼ 226) or
a single Hylan G-F 20 (Synvisc-One) injection (n ¼ 368). "Responders"
to the HA injections were operationally deﬁned as 1) Patients who had
a KOS change score greater than 10 points or 2) Patients who showed
any increase in KOS scores. Self-reported knee function, ranked as
“Severely Abnormal”, “Abnormal”, “Nearly Normal”, or “Normal” was
evaluated at baseline to stratify groups if a signiﬁcant interaction effect
was found. “Normal” subjects were subjects without functional limi-
tations, but may have had pain or were known to have chondral lesions.
A repeated measures ANOVA was used to assess change in KOS score
between injection types and over time. Chi-square analysis was used to
determine differences in the responder rate between injection types
and determine if therewas a relationship between change perception of
function (KOS and GRS) and baseline self-reported knee function.
Results: 594 knees were assessed and time between ﬁrst injection and
follow-up was 78 +/- 13 days for patients who received Sodium Hya-
luronate and 46 +/- 15 days for patients who received Hylan G-F 20.
There was a signiﬁcant Self-Function by Time interaction effect
(p0.002) and those with lower reported self-functional score
(abnormal, severely abnormal) demonstrated greater improvement in
KOS and GRS scores at follow-up (Figures 1 and 2). There was no
Injection Type by Time interaction effect and no difference in responder
rates when stratiﬁed by injection type suggesting no difference in
outcomes between the multi or single injection (p>0.455). Most
patients patients demonstrated some improvement on the KOS at
follow-up, although a smaller number of individuals achieved a 10 point
change on the KOS (Table 1).
Conclusions:HA injections offer small, but signiﬁcant improvements in
self-reported function for the majority of patients with OA. There was
no additional functional beneﬁt to using one particular formulation.
Patients who report their knee function as abnormal or severely
abnormal at baseline are most likely to have a larger response at follow-




INTRA ARTICULAR DRUG DELIVERY THROUGH AN IN-SITU GELLING
SYSTEM
M.J. Sandker y, A. Petit z, P. de Bruin z, R. Meyboom z, M. Siebelt y, W.E.
Hennink x, H.H. Weinans y. yDept. of Orthopedic Surgery, Erasmus Med.
Ctr., Rotterdam, The Netherlands; z InGell Labs BV, Groningen, The
Netherlands; xDept. of Pharmaceutics, Utrecht Inst. for Pharmaceutical
Sci., Utrecht, The Netherlands
Purpose: Our aim was to develop a biodegradable, in situ forming gel
suitable for prolonged, i.e. several weeks, intra-articular drug delivery.
Gel degradation kinetics, visualization, drug release and intra-articular
biocompatibility were tested
Methods: Gel synthesis PCLA-PEG-PCLA synthesis was performed by
ring opening polymerization of L-lactide and ε-caprolactone in solution
using PEG1500-diol as macroinitiator and tin(II) 2-ethylhexanoate as
catalyst. To gain radiopacity, TIBO-capping of the PCLA-PEG-PCLA was
perfomed using an excess of TIBO chloride. In-vitro gel behavior Phos-
phate buffer was added to the polymer (25wt %) and the resulting gel
was kept at 37 C for the duration of the experiment. At predetermined
time points, residual gel weight was measured. In-vivo experiments
Group 1 (n¼6 male Wistar rats); 100ml radiopaque gel was injected
subcutaneous (n¼4) or in the knee joint (n¼2) and scanned regularly to
visualize in vivo gel degradation longitudinally. Attenuation and volume
of the gels were calculated. Group 2 (n¼10); 50 ml non-radiopaque gel
was injected in the left knee, the right knee served as a control (50ml
saline). mCT arthographies were acquired before injection, after 6 and 12
weeks to monitor cartilage quality (sGAG content is correlated inversely
to Hexabrix inﬂux) and quantity over time. After the last scan, knees
were harvested for histology. Group 3 (n¼5); 500 ml of Celecoxib loaded
gels (60 mg/g) were injected subcutaneously and blood samples were
taken regularly to analyze drug release with UPLC.
Results: In-vitro gel degradation Complete gel degradation tookw130-
140 days. Gel attenuation corresponded well with the measured poly-
mer concentration over time, proving that mCT is indeed a good tech-
nique to quantify the amount of polymer present. In-vivo experiments
Group 1: Total gel volume directly after subcutaneous injection by mCT
was set at 100% and for all following time points the percentage of
residual volume was calculated (ﬁgure 1). A controlled degradation was
observed for period of twelve weeks. Upon intra-articular injection, the
